
Charles River Laboratories International CRL
$ 210.33
-0.07%
Quarterly report 2025-Q3
added 11-05-2025
Charles River Laboratories International P/E Ratio 2011-2026 | CRL
Annual P/E Ratio Charles River Laboratories International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 385 | 26.3 | 22.7 | 37.5 | 38.9 | 30.5 | 25.7 | 42.3 | 23.8 | 24.2 | 26.5 | 26.9 | 21 | 15.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 385 | 15.5 | 53.3 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
-0.00947 | $ 2.96 | -2.8 % | $ 96.1 K | ||
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 40.46 | 2.7 % | $ 1.12 B | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 35.0 | 2.76 % | $ 374 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 24.11 | 3.1 % | $ 99.4 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 102.49 | 0.15 % | $ 19 B | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.26 | -3.14 % | $ 1.6 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-13.4 | $ 115.34 | 1.14 % | $ 14.2 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
39 | $ 218.15 | -0.34 % | $ 159 B | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 67.61 | 1.04 % | $ 4.68 B | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
25.2 | $ 584.92 | 0.42 % | $ 18.1 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
90.1 | $ 73.25 | 0.29 % | $ 28.3 B | ||
|
NeoGenomics
NEO
|
-19.4 | $ 12.26 | 1.66 % | $ 1.55 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 21.05 | 2.41 % | $ 1.13 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 21.26 | 4.52 % | $ 522 M | ||
|
Celcuity
CELC
|
-3.57 | $ 111.78 | 2.16 % | $ 4.41 B | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.2 | 1.8 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.41 | 0.8 % | $ 799 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 28.7 | - | $ 20 B | ||
|
Personalis
PSNL
|
-3.12 | $ 9.47 | 1.07 % | $ 561 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 643.53 | -4.02 % | $ 53.1 B | ||
|
Illumina
ILMN
|
-13.4 | $ 141.7 | -2.15 % | $ 22.5 B | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
26 | $ 229.93 | -0.1 % | $ 41.7 B | ||
|
Thermo Fisher Scientific
TMO
|
32.5 | $ 579.47 | 0.25 % | $ 221 B | ||
|
Trinity Biotech plc
TRIB
|
129 | $ 0.82 | 0.51 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 46.54 | 13.32 % | $ 2.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 183.98 | -1.63 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 9.37 | -7.87 % | $ 1.22 B | ||
|
Precipio
PRPO
|
-1.49 | $ 24.54 | 0.04 % | $ 31.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 268.23 | -1.21 % | $ 22.5 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 178.87 | -0.77 % | $ 14.8 B |